Raltegravir
Back to searchMolecule Structure
Scientific Name
Raltegravir
Description of the Drug
Raltegravir is an antiretroviral agent used for the treatment of HIV infections in conjunction with other antiretrovirals.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06817
http://www.drugbank.ca/drugs/DB06817
Brand Name(s)
Isentress
Company Owner(s)
Merck Sharp And Dohme Llc A Sub Of Merck And Co Inc, Merck Sharp And Dohme Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 integrase | SINGLE PROTEIN | INHIBITOR | CHEMBL3471 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL51817 | ||
| Human Metabolome Database | HMDB0241916 | ||
| DrugBank | DB06817 | ||
| PubChem: Thomson Pharma | 16707449 | ||
| PubChem | 54671008 | ||
| Mcule | MCULE-4916399246 | ||
| LINCS | LSM-5233 | ||
| Nikkaji | J2.509.696G | ||
| PDBe | RLT | ||
| BindingDB | 25351 | ||
| EPA CompTox Dashboard | DTXSID2048660 | ||
| DrugCentral | 2352 | ||
| Brenda | 41559 | ||
| ChemicalBook | CB61456530 | ||
| rxnorm | ISENTRESS | RALTEGRAVIR | RALTEGRAVIR POTASSIUM |
| ChEBI | 82960 | ||
| ZINC | ZINC000013831130 |
